by on 15 hours ago
Modafinil, a wakefulness-selling agent, has garnered important attention since its approval by the FDA in 1998 for the treatment of narcolepsy, a condition characterized by extreme daytime sleepiness. As the demand for cognitive enhancers has risen, modafinil has attracted interest not only within clinical settings but in addition amongst healthy individuals looking for to enhance their cognitive features. This case research goals to guage the efficacy, safety, and varied use instances of modafi...
3 views 0 likes